Why is Insmed, Inc. ?
- The company has declared positive results for the last 2 consecutive quarters
- NET SALES(Q) Highest at USD 305.96 MM
- OPERATING PROFIT MARGIN(Q) Highest at -63.6 %
- RAW MATERIAL COST(Y) Fallen by -10.84% (YoY)
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Along with generating 40.12% returns in the last 1 year, the stock has outperformed S&P 500 in each of the last 3 annual periods
How much should you buy?
- Overall Portfolio exposure to Insmed, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Insmed, Inc. for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD 305.96 MM
Highest at -63.6 %
Fallen by -10.84% (YoY
Highest at USD 2,653.56 MM
Highest at 1.33 times
Highest at USD -194.59 MM
Highest at USD -209.06 MM
Highest at USD -210.52 MM
Highest at USD -0.76
Lowest at USD -895.67 MM
Lowest at 7.24 times
Here's what is working for Insmed, Inc.
Net Sales (USD MM)
Net Sales (USD MM)
Operating Profit to Sales
Operating Profit (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Cash and Cash Equivalents
Inventory Turnover Ratio
Raw Material Cost as a percentage of Sales
Depreciation (USD MM)
Here's what is not working for Insmed, Inc.
Operating Cash Flows (USD MM)
Debtors Turnover Ratio






